BREAST CANCER, HR+/HER2- EARLY-STAGE

Clinical trials for BREAST CANCER, HR+/HER2- EARLY-STAGE explained in plain language.

Never miss a new study

Get alerted when new BREAST CANCER, HR+/HER2- EARLY-STAGE trials appear

Sign up with your email to follow new studies for BREAST CANCER, HR+/HER2- EARLY-STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New tool aims to predict which breast cancers might return

Knowledge-focused Not yet recruiting

This study aims to create a prediction tool (called a nomogram) for a common type of early breast cancer (HR+/HER2-). Researchers will look back at the medical records of about 500 past patients to find patterns that predict whose cancer might return. The goal is to help doctors …

Matched conditions: BREAST CANCER, HR+/HER2- EARLY-STAGE

Sponsor: Shengjing Hospital • Aim: Knowledge-focused

Last updated Apr 03, 2026 14:43 UTC

BREAST CANCER, HR+/HER2- EARLY-STAGE

Get alerted when new BREAST CANCER, HR+/HER2- EARLY-STAGE trials appear

New tool aims to predict which breast cancers might return